Categories: Tech

Synaptics to Report First Quarter Fiscal 2026 Results on November 6, 2025

SAN JOSE, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) — Synaptics® Incorporated (Nasdaq: SYNA) today announced that it will report financial results for the first quarter of fiscal 2026 on Thursday, November 6, 2025, after the market closes. The Company will host a corresponding conference call for analysts and investors at 2:00 p.m. PT (5:00 p.m. ET), to discuss the results.

To participate on the live call, analysts and investors should pre-register at Synaptics Q1 FY2026 Earnings Call Registration.
https://register-conf.media-server.com/register/BIe73f881f7c8144eda6755f8f7fb25d97

Registrants will receive dial-in information and a unique passcode to access the call. We encourage participants to dial-in at least ten minutes before the scheduled start time.

A live and archived webcast of the conference call, as well as associated materials, will be accessible from the “Investor Relations” section of the Company’s website at https://investor.synaptics.com.

About Synaptics Incorporated:
Synaptics (Nasdaq: SYNA) is driving innovation in AI at the Edge, bringing AI closer to end users and transforming how we engage with intelligent connected devices, whether at home, at work, or on the move. As a go-to partner for forward-thinking product innovators, Synaptics powers the future with its cutting-edge Synaptics Astra™ AI-Native embedded compute, Veros™ wireless connectivity, and multimodal sensing solutions. We’re making the digital experience smarter, faster, more intuitive, secure, and seamless. From touch, display, and biometrics to AI-driven wireless connectivity, video, vision, audio, speech, and security processing, Synaptics is a force behind the next generation of technology enhancing how we live, work, and play. 

Follow Synaptics on LinkedIn, X, and Facebook, or visit www.synaptics.com.

For further information, please contact:
Munjal Shah
VP, Head of Investor Relations
Synaptics
+1-408-518-7639
munjal.shah@synaptics.com

GlobeNews Wire

Recent Posts

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

2 weeks ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

2 weeks ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

3 weeks ago

Secret Ingredient’s 2025: Redefining Hospitality through Story, Space and Strategy

NEW DELHI, Dec. 31, 2025 /PRNewswire/ -- Secret Ingredient, one of India's foremost food and…

4 weeks ago

GAC Receives Industry’s First Vehicle Data Security Management System Certificate

TIANJIN, China and GUANGZHOU, China, Dec. 31, 2025 /PRNewswire/ -- On December 24th, GAC received…

4 weeks ago